© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Q3 Medical Devices is looking to raise around €125m ($142m) through an IPO in Hong Kong, according to a release.
  • Malaysia's securities regulator has upheld its decision to penalise those involved in the listing scandal of Lotte Chemical Titan after dismissing the review applications.
  • Volatility has returned to equity capital markets, derailing indices and making new capital raising much more difficult. ECM deals can still offer investors a way to outperform, but when markets are tough, their risk appetite shrivels. Many political shocks could hurt in 2019, starting with Brexit and a global trade war. But overshadowing all this is the fear that a more profound pessimism has returned to stalk equity markets, after their long upward decade. Sam Kerr reports.
  • A host of emerging market opportunities are set to be presented to equity investors in 2019 with Kazakhstan likely to lead the way with a number of highly anticipated listings. Sam Kerr reports.
  • Falling global stock markets and and billions of dollars of equity fund redemptions mean ECM bankers will have to be careful with what deals they bring when markets reopen in January.
  • Deloitte is predicting a major decline in Hong Kong IPO volumes next year, in large part because of uncertainty in the global economic outlook.